Merck’s new COVID-19 pill will save lives, but at what price?

18/10/2021 28 min Temporada 1 Episodio 9
Merck’s new COVID-19 pill will save lives, but at what price?

Listen "Merck’s new COVID-19 pill will save lives, but at what price?"

Episode Synopsis

Joseph Allen, executive director of the Bayh-Dole Coalition, explains how molnupiravir, from Ridgeback Biotherapeutics, and partner Merck & Co. Inc., may have never had a chance to move out of the university onto pharmacy shelves without the government’s support.   Hosted on Acast. See acast.com/privacy for more information.

More episodes of the podcast The BioWorld Insider Podcast